Document is current
Any future updates will be listed below
-
Authors
Sanford, Brandon T.
Toll, Benjamin A.
Eckard, Allison Ross
Sterba, Katherine R.
Cummings, K. Michael
Baker, Nathaniel L.
Rojewski, Alana M. http://orcid.org/0000-0003-1531-9287
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (K07CA214839, R01CA261232)
- License Information
-
More Information
Article History
Received: 9 May 2022
Revised: 9 May 2022
Accepted: 3 October 2022
First Online: 5 November 2022
Declarations
:
: This study has been reviewed and approved by the MUSC Institutional Review Board (IRB), which serves as the IRB of record (Pro00107332, last approved 1/18/2022).
: This study has been reviewed and approved by the Medical University of South Carolina Institutional Review Board (Pro00107332). Dissemination of scientific results will be conducted through traditional research-oriented outlets such as presentations at scientific meetings and publications in peer-reviewed journals. After the study data is collected and cleaned and the primary paper is published, anonymized study data will be available for research purposes to individuals within the scientific community by request.
: BAT has consulted to Pfizer for an advisory board on e-cigarettes. BAT and KMC testify as expert witnesses on behalf of plaintiffs who filed litigation against the tobacco industry.
: Not applicable.
